Citation tools
"Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial." Stroke and Vascular Neurology
9.5
(2024):
568-573.
Web. 21 June. 2025.